Advertisement
A live audio webcast of Uroplasty's presentation may be accessed throughthe Company's website at http://www.uroplasty.com. An archived replay of thepresentation will be available after the live presentation, and can also beaccessed at http://www.uroplasty.com.
Advertisement
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-ownedsubsidiaries in The Netherlands and the United Kingdom, is a medical devicecompany that develops, manufactures and markets innovative proprietaryproducts for the treatment of voiding dysfunctions. Our primary focus is thecommercialization of our Urgent PC system, which we believe is the onlyFDA-approved minimally invasive nerve stimulation device designed foroffice-based treatment of urinary urgency, urinary frequency and urgeincontinence -- symptoms often associated with overactive bladder. We alsooffer Macroplastique(R) Implants, an injectable bulking agent for thetreatment of adult female stress urinary incontinence pimarily due tointrinsic sphincter deficiency. Please visit Uroplasty, Inc. athttp://www.uroplasty.com.For Further Information: Uroplasty, Inc. EVC Group David Kaysen, President and CEO, or Dahlia Bailey (Investors) Medi Jiwani, Vice President, CFO, 415.896.5862 and Treasurer, 952.426.6140 Steve DiMattia/Chris Gale (Media) 646.201.5445
SOURCE Uroplasty, Inc.
